1
|
Stout JE and Yu VL: Legionellosis. New Eng
J Med. 337:682–687. 1997. View Article : Google Scholar : PubMed/NCBI
|
2
|
Helms CM, Viner JP, Weisenburger DD, Chiu
LC, Renner ED and Johnson W: Sporadic legionnaires' disease:
Clinical observations on 87 nosocomial and community-acquired
cases. Am J Med Sci. 288:2–12. 1984. View Article : Google Scholar : PubMed/NCBI
|
3
|
Pedro-Botet ML, Sabria-Leal M, Sopena N,
Manterola JM, Morera J, Blavia R, Padilla E, Matas L and Gimeno JM:
Role of immunosuppression in the evolution of Legionnaires'
disease. Clin Infect Dis. 26:14–19. 1998. View Article : Google Scholar : PubMed/NCBI
|
4
|
Beaute J, Zucs P and de Jong B; European
Legionnaires' Disease Surveillance Network, : Legionnaires disease
in Europe, 2009–2010. Euro Surveill. 18:204172013. View Article : Google Scholar : PubMed/NCBI
|
5
|
Clark SB and Soos MP: Noncardiogenic
Pulmonary Edema. StatPearls. StatPearls Publishing LLC. (Treasure
Island (FL)). 2019.https://www.ncbi.nlm.nih.gov/books/NBK542230/
|
6
|
Htwe TH and Khardori NM: Legionnaire's
disease and immunosuppressive drugs. Infect Dis Clin North Am.
31:29–42. 2017. View Article : Google Scholar : PubMed/NCBI
|
7
|
Lo SK, Everitt J, Gu J and Malik AB: Tumor
necrosis factor mediates experimental pulmonary edema by ICAM-1 and
CD18-dependent mechanisms. J Clin Invest. 89:981–988. 1992.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Donners MM, Wolfs IM, Olieslagers S,
Mohammadi-Motahhari Z, Tchaikovski V, Heeneman S, van Buul JD,
Caolo V, Molin DG, Post MJ and Waltenberger J: A disintegrin and
metalloprotease 10 is a novel mediator of vascular endothelial
growth factor-induced endothelial cell function in angiogenesis and
is associated with atherosclerosis. Arterioscler Thromb Vasc Biol.
30:2188–2195. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Edelstein PH: Legionella jamestowniensis
fatal pneumonia in an immunosuppressed man. J Infect Chemother.
23:59–61. 2017. View Article : Google Scholar : PubMed/NCBI
|
10
|
Nanovic Z: Legionnaires' disease and use
of tumor necrosis factor-αlpha inhibitors: A forthcoming problem?
Macedonian. J Med Sci. 6:465–472. 2013.
|
11
|
Kirkpatrick WR, McAtee RK, Fothergill AW,
Rinaldi MG and Patterson TF: Efficacy of voriconazole in a guinea
pig model of disseminated invasive aspergillosis. Antimicrob Agents
Chemother. 44:2865–2868. 2000. View Article : Google Scholar : PubMed/NCBI
|
12
|
Gamradt P, Xu Y, Gratz N, Duncan K, Kobzik
L, Högler S, Kovarik P, Decker T and Jamieson AM: The influence of
programmed cell death in myeloid cells on host resilience to
infection with legionella pneumophila or streptococcus
pyogenes. PLoS Pathog. 12:e10060322016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Ismael-Badarneh R, Guetta J, Klorin G,
Berger G, Abu-Saleh N, Abassi Z and Azzam ZS: The role of
angiotensin II and cyclic AMP in alveolar active sodium transport.
PLoS One. 10:e01341752015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Ong HX, Benaouda F, Traini D, Cipolla D,
Gonda I, Bebawy M, Forbes B and Young PM: In vitro and ex vivo
methods predict the enhanced lung residence time of liposomal
ciprofloxacin formulations for nebulisation. Eur J Phar Biopharm.
86:83–89. 2014. View Article : Google Scholar
|
15
|
Kadlecek S, Shaghaghi H, Siddiqui S,
Profka H, Pourfathi M and Rizi R: The effect of exogenous substrate
concentrations on true and apparent metabolism of hyperpolarized
pyruvate in the isolated perfused lung. NMR Biomed. 27:1557–1570.
2014. View
Article : Google Scholar : PubMed/NCBI
|
16
|
Dominguez-Fandos D, Valdes C, Ferrer E,
Puig-Pey R, Blanco I, Tura-Ceide O, Paul T, Peinado VI and Barberà
JA: Sildenafil in a cigarette smoke-induced model of COPD in the
guinea-pig. Eur Respir J. 46:346–354. 2015. View Article : Google Scholar : PubMed/NCBI
|
17
|
He X, Liang Y, LaValley MP, Lai J and
Ingalls RR: Comparative analysis of the growth and biological
activity of a respiratory and atheroma isolate of chlamydia
pneumoniae reveals strain-dependent differences in inflammatory
activity and innate immune evasion. BMC Microbiol. 15:2282015.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Wang E, Simard M, Ouellet N, Bergeron Y,
Beauchamp D and Bergeron MG: Pathogenesis of pneumococcal pneumonia
in cyclophosphamide-induced leukopenia in mice. Infect Immun.
70:4226–4238. 2002. View Article : Google Scholar : PubMed/NCBI
|
19
|
Machireddy K, Myint Z, Dein E, Mathai SC,
Seo P, Haque U, Manno R and Timlin H: Mycophenolate mofetil in a
lupus patient with pulmonary hypertension. Cureus.
10:e21212018.PubMed/NCBI
|
20
|
Jais X, Launay D, Yaici A, Le Pavec J,
Tchérakian C, Sitbon O, Simonneau G and Humbert M:
Immunosuppressive therapy in lupus- and mixed connective tissue
disease-associated pulmonary arterial hypertension: A retrospective
analysis of twenty-three cases. Arthritis Rheum. 58:521–531. 2008.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Bates DO: Vascular endothelial growth
factors and vascular permeability. Cardiovas Res. 87:262–271. 2010.
View Article : Google Scholar
|
22
|
Dejana E and Giampietro C: Vascular
endothelial-cadherin and vascular stability. Curr Opin Hematol.
19:218–223. 2012. View Article : Google Scholar : PubMed/NCBI
|
23
|
Komarova Y and Malik AB: Regulation of
endothelial permeability via paracellular and transcellular
transport pathways. Ann Rev Physiol. 72:463–493. 2010. View Article : Google Scholar
|
24
|
Komarova YA, Mehta D and Malik AB: Dual
regulation of endothelial junctional permeability. Sci STKE.
2007:re82007. View Article : Google Scholar : PubMed/NCBI
|
25
|
Weiss SJ: Tissue destruction by
neutrophils. N Engl J Med. 320:365–376. 1989. View Article : Google Scholar : PubMed/NCBI
|
26
|
Lampugnani MG, Resnati M, Raiteri M,
Pigott R, Pisacane A, Houen G, Ruco LP and Dejana E: A novel
endothelial-specific membrane protein is a marker of cell-cell
contacts. J Cell Biol. 118:1511–1522. 1992. View Article : Google Scholar : PubMed/NCBI
|
27
|
Lan CC, Peng CK, Tang SE, Wu SY, Huang KL
and Wu CP: Anti-vascular endothelial growth factor antibody
suppresses ERK and NF-κB activation in ischemia-reperfusion lung
injury. PLoS One. 11:e01599222016. View Article : Google Scholar : PubMed/NCBI
|
28
|
Rieg AD, Suleiman S, Perez-Bouza A,
Braunschweig T, Spillner JW, Schröder T, Verjans E, Schälte G,
Rossaint R, Uhlig S and Martin C: Milrinone relaxes pulmonary veins
in guinea pigs and humans. PLoS One. 9:e876852014. View Article : Google Scholar : PubMed/NCBI
|
29
|
Viswanathan VK, Edelstein PH, Pope CD and
Cianciotto NP: The legionella pneumophila iraAB locus is required
for iron assimilation, intracellular infection, and virulence.
Infect Immun. 68:1069–1079. 2000. View Article : Google Scholar : PubMed/NCBI
|
30
|
Edelstein PH: The guinea pig model of
legionnaires' disease. Methods Mol Biol. 954:521–540. 2013.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Wang X, Ma S, Liu Y, Xu W and Li Z:
Effects and mechanism analysis of combined infusion by levosimendan
and vasopressin on acute lung injury in rats septic shock. Cell
Biochem Biophys. 70:1639–1645. 2014. View Article : Google Scholar : PubMed/NCBI
|
32
|
Daudel F, Tuller D, Krahenbuhl S, Jakob SM
and Takala J: Pulse pressure variation and volume responsiveness
during acutely increased pulmonary artery pressure: An experimental
study. Crit Care. 14:R1222010. View
Article : Google Scholar : PubMed/NCBI
|